title: Depressive symptoms in the perimenopause: prevalence, assessment, and guidelines for treatment.
abstract: This review describes the biological changes occurring in perimenopause and analyzes epidemiological studies that shed light on the relationship between perimenopause and mood. The role of estrogen as a treatment for depressive symptoms is also examined. We found that a positive association may exist between depressive symptoms and the perimenopause, and that a prior history of depression may be associated with such symptoms. In most of the studies reviewed, the use of estrogen in replacement doses appears to improve depressive symptoms in perimenopausal patients who do not have major depression. We suggest an approach to the treatment of middle-aged women presenting with such symptoms. No careful study of the incidence of DSM-IV major depression associated with perimenopause has been done, and the efficacy of estrogen as a primary or adjunctive treatment for the disorder during perimenopause is unclear.
authors.affiliation: UCLA Neuropsychiatric Hospital, USA.
authors.forename: V K
authors.initials: VK
authors.lastname: Burt
authors.forename: L L
authors.initials: LL
authors.lastname: Altshuler
authors.forename: N
authors.initials: N
authors.lastname: Rasgon
mesh_terms: D000328:Adult; D003866:Depressive Disorder / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D008875:Middle Aged; D017698:Postmenopause / Q000523:psychology*; D017697:Premenopause / Q000523:psychology*; D015995:Prevalence
chemical_list: D004967:Estrogens; D005640:Follicle Stimulating Hormone